Successful outcome after evacuation of intracranial hematoma following thrombolysis in acute myocardial infarction.

Abstract

Thrombolytic therapy is the modality of choice for the treatment of life threatening thrombosis in various vascular territories and nowadays, is used extensively in setting of acute myocardial infarction. There is, however, the omnipresent danger of serious bleeding inherently associated with the use of all thrombolytics which if it occurs in the brain, can lead to potentially serious neurological impairment and even death. In our report, we describe the successful surgical management of a streptokinase-induced intracranial hemorrhage. Timely neurosurgical intervention is advocated as the optimal approach for this particular side effect of thrombolytic agents.

• Authors: Tarig S Al Khuwaitir, Bashir A Wani, Helmi A Dawood, Mohammed A Khan
• Journal: Saudi medical journal (Saudi Med J) Vol. 26 Issue 1 Pg. 130-2 (Jan 2005) ISSN: 0379-5284 [Print] Saudi Arabia
• PMID: 15756370 (Publication Type: Case Reports, Journal Article)

Chemical References

• Fibrinolytic Agents
• Streptokinase

Topics

• Adult
• Cerebral Hemorrhage (chemically induced, surgery)
• Fibrinolytic Agents (adverse effects)
• Hematoma (chemically induced, surgery)
• Humans
• Male
• Myocardial Infarction (drug therapy)
• Streptokinase (adverse effects)
• Thrombolytic Therapy (adverse effects)